Kevin Weil's AI Science Startup Seeks $150M Round
Kevin Weil's AI science startup is seeking at least $150 million in funding at a valuation of $750 million or more, according to Business Insider. The venture has not yet revealed a public name or shipped a product. The former OpenAI chief product officer left the company in April after leading its science division, and the reported plan is to build AI systems that gather scientific data for model training and accelerate research workflows. The fundraising effort surfaced this week.
The figures are reports rather than closed terms, and numbers of this size often shift between first reports and final close, so they should be read as the starting point of the round. The structure of the deal matters more than the headline. A $150 million raise at a $750 million-plus valuation is a bet on two things at once: Weil's record as a product leader across OpenAI, Instagram, and Twitter, and the claim that scientific data is becoming one of the scarcest inputs in AI. With no shipped product to underwrite the number, the valuation is a statement about the founder and the thesis rather than about traction.
Weil spent roughly two years at OpenAI, joining as chief product officer in 2024 and later founding and leading the research group known as OpenAI for Science, launched in 2025, where he helped shape the rise of ChatGPT. On his last day at the company in April, he said the group was being decentralized into other research teams. His earlier career includes head-of-product roles at Instagram and Twitter, the presidency of satellite imagery company Planet, and a founding role on the Libra cryptocurrency project. He also holds board seats at Cisco, reusable-rocket builder Stoke Space, and The Nature Conservancy. Weil has not publicly commented on the reported raise.
What Kevin Weil's AI science startup is building
The venture is a data play rather than a model lab. Collecting scientific data for AI models means assembling the raw material research-heavy fields produce: experimental results, instrument outputs, measurements, and structured knowledge currently scattered across institutions, journals, and private databases. Frontier labs have largely exhausted the easy supply of human-written text, and scientific data is one of the few large, mostly uncollected pools left. The bet behind the AI science startup is that the pipeline rather than the model will decide where the next advantage is built.
The customers for such a pipeline are not yet public. Model labs that need specialized training data are the obvious market, because frontier models have consumed most available text. Research organizations are another, since automating data collection would compress the time between experiment and result. That focus explains why the company can stay unnamed and productless at this stage: the pitch to investors rests on pipeline construction, and whoever controls clean, well-labeled scientific data will control a meaningful share of what next-generation models can learn in fields like biomedicine, materials science, and climate research.
Weil's AI science startup effectively continues work he began at OpenAI. OpenAI for Science was created in 2025 to explore how AI could support researchers, and its dissolution into Codex earlier this year freed Weil to pursue the same mission with outside capital. That continuity is part of the pitch: the program's outline is already visible to investors, which lowers the perceived risk of an otherwise unnamed company.
Scientific data is also unusually high-stakes. A model trained on a flawed lab result can propagate the error into every downstream decision, which is why quality control will be a core part of the offering. That makes the data work harder than typical web scraping: it requires domain expertise, verification processes, and relationships with the institutions that generate the data. None of that is cheap, which is part of why the round is as large as it is.
A no-product round with a founder premium
The valuation puts Weil's venture in company with other pedigree-led rounds in 2026. Recursive Superintelligence, a four-month-old startup founded by former DeepMind and OpenAI engineers and focused on self-teaching AI, raised more than $500 million earlier this year. Taken together, the two rounds show that investors will price founder reputation and a thesis before either company has a market product. The category is drawing capital from across the industry, and both bets assume AI's next frontier is scientific discovery itself.
There is a trade-off for the backers. A product-less round means the valuation rests on execution risk, and science-data collection is expensive to scale: it depends on partnerships with institutions, instrumentation, compute capacity, and specialists who understand both AI and domain science. If the pipeline materializes, the company owns an asset competitors cannot easily copy. If it stalls, there is little to salvage beyond the team itself.
The size of the raise also signals the cost structure Weil expects. At $150 million, this would be one of the larger early-stage financings of the year, and it points to capital-intensive work ahead rather than a lean software build. Weil also had alternatives to founding his own AI science startup: another frontier lab, a research-institute role, or staying in investing through Scribble Ventures. Choosing an independent company gives him full equity upside and control over direction, at the cost of giving up the resources of a large lab. That trade-off is visible in the round itself, which rewards independence while paying for the infrastructure OpenAI would have provided.
The OpenAI exit wave behind the timing
The fundraise follows a busy stretch of departures at OpenAI. Weil announced his exit on April 17, 2026, the same day as Bill Peebles, the researcher behind the video tool Sora, and Srinivas Narayanan, as the company dissolved its science division and folded the AI science application into Codex. The pattern is consistent: OpenAI consolidating side projects into core products, while senior talent departs to raise capital on its own terms.
Weil has kept a hand in startups beyond his own. Through Scribble Ventures, the fund he runs with his wife Elizabeth, he invested early in Stoke Space and joined its board in July ahead of the Nova rocket's debut flight. That mix of board seats, investing, and a new venture gives him the network a data-heavy startup needs to negotiate access to research institutions.
What to watch next
Three things will test the thesis. The public debut: the name, the product, and the leadership team, none of which have been revealed. The investor lineup: whether the round is led by generalist growth funds or by investors with research and life-science expertise. And the first commercial relationships, since a data company only becomes profitable through the customers that license its output.
For enterprises in research-heavy industries, the round is a signal that scientific data is being priced as strategic infrastructure. Whoever builds these pipelines will set the terms for how data is licensed, shared, and bundled with model access, which will shape procurement decisions across pharma, materials, and energy over the next several years. The reported terms also set a benchmark: other founders raising for AI-for-science work can point to the $750 million figure when justifying their own valuations.
Why this matters
This round shows that a founder-led AI science startup can command nine-figure valuations before a product exists. For decision-makers, it is a reminder that the next competitive bottleneck in AI is likely to be data collection rather than model architecture, and that the companies building those pipelines deserve as much scrutiny as the labs training the models.
Photo by Vitaliy Shevchenko on Unsplash
Related Articles
- DeepSeek Funding Round Targets $10B Valuation
- Generalist AI Funding Round Secures $400 Million to Advance Physical AGI
- Isomorphic Labs Secures $2.1 Billion to Advance AI Drug Discovery Platform
✔Human Verified
Researched and cross-referenced against primary sources by the Bytevyte editorial team. This article was generated with the assistance of artificial intelligence and reviewed by the Bytevyte editorial team.